End-of-day quote
Shanghai S.E.
23:00:00 27/06/2024 BST
|
5-day change
|
1st Jan Change
|
6.2
CNY
|
-0.48%
|
|
-3.58%
|
-16.67%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,779
|
12,850
|
8,113
|
7,769
|
6,474
|
-
|
-
|
Enterprise Value (EV)
1 |
7,779
|
12,850
|
8,113
|
7,769
|
6,474
|
6,474
|
6,474
|
P/E ratio
|
16.3
x
|
-
|
19
x
|
62
x
|
14.8
x
|
8.55
x
|
7.85
x
|
Yield
|
2.37%
|
8.27%
|
1.67%
|
1.84%
|
2.26%
|
3.71%
|
-
|
Capitalization / Revenue
|
0.87
x
|
0.96
x
|
0.6
x
|
0.6
x
|
0.45
x
|
0.37
x
|
0.32
x
|
EV / Revenue
|
0.87
x
|
0.96
x
|
0.6
x
|
0.6
x
|
0.45
x
|
0.37
x
|
0.32
x
|
EV / EBITDA
|
8.9
x
|
-
|
-
|
9.24
x
|
4.1
x
|
2.86
x
|
2.47
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.61
x
|
1.69
x
|
1.08
x
|
0.99
x
|
0.8
x
|
0.75
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
837,376
|
1,032,121
|
1,044,176
|
1,044,178
|
1,044,179
|
-
|
-
|
Reference price
2 |
9.290
|
12.45
|
7.770
|
7.440
|
6.200
|
6.200
|
6.200
|
Announcement Date
|
23/04/21
|
30/03/22
|
30/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
8,912
|
13,415
|
13,559
|
12,919
|
14,306
|
17,544
|
19,961
|
EBITDA
1 |
874.4
|
-
|
-
|
840.7
|
1,580
|
2,264
|
2,618
|
EBIT
1 |
447.8
|
2,474
|
493.1
|
299
|
556
|
962.5
|
1,235
|
Operating Margin
|
5.02%
|
18.44%
|
3.64%
|
2.31%
|
3.89%
|
5.49%
|
6.19%
|
Earnings before Tax (EBT)
1 |
432.5
|
-
|
493.4
|
308.3
|
556
|
963
|
1,235
|
Net income
1 |
370.6
|
2,144
|
426.8
|
123.4
|
438.5
|
757.1
|
820
|
Net margin
|
4.16%
|
15.98%
|
3.15%
|
0.95%
|
3.06%
|
4.32%
|
4.11%
|
EPS
2 |
0.5700
|
-
|
0.4100
|
0.1200
|
0.4200
|
0.7250
|
0.7900
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2200
|
1.030
|
0.1300
|
0.1370
|
0.1400
|
0.2300
|
-
|
Announcement Date
|
23/04/21
|
30/03/22
|
30/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.47%
|
33.2%
|
5.69%
|
1.55%
|
5.48%
|
8.84%
|
9.2%
|
ROA (Net income/ Total Assets)
|
1.83%
|
9.33%
|
1.6%
|
0.41%
|
1.3%
|
2.25%
|
2.2%
|
Assets
1 |
20,263
|
22,988
|
26,623
|
30,091
|
33,728
|
33,649
|
37,273
|
Book Value Per Share
2 |
5.760
|
7.390
|
7.190
|
7.500
|
7.760
|
8.220
|
8.540
|
Cash Flow per Share
2 |
0.3500
|
1.380
|
0.8100
|
0.2800
|
1.550
|
1.950
|
-
|
Capex
1 |
-
|
2,264
|
2,198
|
2,250
|
3,554
|
2,800
|
2,192
|
Capex / Sales
|
-
|
16.88%
|
16.21%
|
17.41%
|
24.84%
|
15.96%
|
10.98%
|
Announcement Date
|
23/04/21
|
30/03/22
|
30/03/23
|
19/03/24
|
-
|
-
|
-
|
Average target price
9.3
CNY Spread / Average Target +50.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.67% | 891M | | +19.99% | 67.97B | | -6.03% | 45.92B | | +22.27% | 43.74B | | +33.20% | 28.16B | | +8.15% | 19.17B | | +14.71% | 17.12B | | -13.18% | 14.73B | | -27.99% | 14.52B | | -32.33% | 11.64B |
Other Specialty Chemicals
|